Abstract
Polymorphisms in genes coding for pro-inflammatory molecules represent important factors for the pathogenesis and outcome of stroke. The aim of this study was to evaluate the relationship between the tumor necrosis factor beta (TNF-β) NcoI (rs909253) polymorphism with inflammatory and metabolic markers in acute ischemic stroke. Ninety-three patients and 134 controls were included. The TNF-β polymorphism was determined using PCR-RFLP with NcoI restriction enzyme. Stroke subtypes and neurological deficit score were evaluated. White blood cell counts, erythrocyte sedimentation rate (ESR), plasma levels of IL-6 and TNF-α, serum high sensitivity C-reactive Protein (hsCRP), serum lipid profile, plasma levels of glucose and insulin, and homeostatic model assessment of insulin resistance (HOMA-IR) were determined. Stroke patients presented higher white blood cell counts, hsCRP, ESR, glucose, insulin, and HOMA-IR, and lower HDL cholesterol than controls (p < 0.01). There was no difference in genotypic and allelic frequency of TNF-β NcoI polymorphism among patients and controls (p > 0.05). However, stroke patients carrying the TNFB2/B2 genotype presented higher levels of TNF-α, white blood cell counts, total cholesterol, LDL cholesterol, glucose, insulin, and HOMA-IR than those with other genotypes (p < 0.05). White blood cells, IL-6, hsCRP, and ESR were positively correlated with the neurological deficit of the patients (p < 0.05). Taken together, TNF-β NcoI polymorphism, by itself, was not associated with increased susceptibility for stroke development. However, the homozygous genotype for the allele TNFB2 was associated with higher expression of classical inflammatory and metabolic markers of development and outcome of stroke than other genotypes. The identification of variant alleles might allow both better prediction of susceptibility for stroke as well the identification of novel stroke mechanisms that could be target to new therapeutic approaches. Stroke patients carrying the TNFB2 variant allele could have a beneficial effect with the anti-inflammatory therapies in the early inflammatory phase of stroke.
Similar content being viewed by others
References
Adams HP Jr, Bendixen BH, Kappelle JJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions of use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24:35–41
Arenillas JF, Alvarez-Sabín J, Molina CA et al (2003) C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 34:2463–2468
Ariyaratnam R, Casas JP, Whittaker J, Smeeth L, Hingorani AD, Shama P (2007) Genetics of ischemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med 4:e131
Bonita R, Beaglehole R (1988) Modification of Rankin scale: recovery of motor function after stroke. Stroke 19:1497–1500
Braun J, März W, Winkelmann BR, Donner H, Henning Usadel K, Badenhoop K (1998) Tumour necrosis factor beta alleles and hyperinsulinaemia in coronary artery disease. Eur J Clin Invest 28:538–542
Carlson CS, Aldred SF, Lee PK et al (2005) Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 77:64–77
Carter AM, Catto AJ, Bamford JM, Grant PJ (1997) Gender-specific association of the fibrinogen B beta 488 polymorphism, fibrinogen levels, and acute cardiovascular disease. Arterioscler Thromb Vasc Biol 17:589–594
Casas JP, Hingorani AD, Bautista LE, Shama P (2004) Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 61:1652–1661
Chakraborty B, Chowdhury D, Vishnoi G, Goswami B, Kishore J, Agarwal S (2013) Interleukin-6 gene -174G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India. J Stroke Cerebrovasc Dis 22:683–689
Cvetkovic JT, Wiklund PG, Ahmed E, Weinehall L, Hallmans G, Lefvert AK (2005) Polymorphisms of IL-1beta, IL-1Ra, and TNF-alpha genes: a nested case–control study of their association with risk of stroke. J Stroke Cerebrovasc Dis 14:29–35
Delongui F, Carvalho Grion CM, Ehara Watanabe MA et al (2011) Association of tumor necrosis factor β genetic polymorphism and sepsis susceptibility. Exp Ther Med 2:349–356
Den Hertoq A, Van Den Herik EG, Dippel DW, Koudstaal PJ, De Maat MP (2010) Variation in the C-reactive protein gene is associated with serum levels of CRP in patients with acute ischemic stroke. Cerebrovasc Dis 29:372–375
Di Napoli M, Schwaninger M, Cappelli R et al (2005) Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36:1316–1329
Flex A, Gaetani E, Papaleo P et al (2004) Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 35:2270–2275
Freilinger T, Bevan S, Ripke S et al (2009) Genetic variation in the lymphotoxin-alpha pathway and the risk of ischemic stroke in European populations. Stroke 40:970–972
Go AS, Mozaffarian D, Roger VL et al (2014) Heart disease and stroke statistics -2014 update: a report from the american heart association. Circulation 129:e28–e292
Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG (1973) Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52:1544–1568
Grau AJ, Reis A, Buggle F et al (2001) Monocyte function and plasma levels of interleukin-8 in acute ischemic stroke. J Neurol Sci 192:41–47
Gulcher JR, Gretarsdottir S, Helgadottir A, Stefansson K (2005) Genes contributing to risk for common forms of stroke. Trends Mol Med 11:217–224
Haffner SM, Miettinen H, Stern MP (1997) The homeostasis model in San Antonio heart study. Diabetes Care 20:1087–1092
Hagiwara N, Kitazono T, Kamouchi M et al (2008) Polymorphisms in the lymphotoxin alpha gene and the risk of ischemic stroke in the japanese population. The fukuoka stroke registry and the hisayama study. Cerebrovasc Dis 25:417–422
Heinrich PC, Castell JC, Andus T (1990) Interleukin-6 and acute phase response. Biochem J 161:621–636
Hsieh YC, Jeng JS, Lin HJ et al (2012) Epistasis analysis for estrogen metabolic and signaling pathway genes on young ischemic stroke patients. PLoS One 7:e47773
Huizinga TW, Westendorp RG, Bollen EL et al (1997) TNFA promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 72:149–153
IBGE. Brazilian Institute of Geography and Statistics (2011) Characteristics of the Population and Households: Results of the Universe. available in://http://www.ibge.gov.br/english/estatistica/populacao/censo2010/caracteristicas_da_populacao/default_caracteristicas_da_populacao.shtm. Accessed in July 16, 2013
Jang Y, Kim HJ, Koh SJ et al (2007) Lymphotoxin-α gene 252A > G and metabolic syndrome features in Korean men with coronary artery disease. Clin Chim Acta 384:124–128
Kanková K, Márová I, Jansen EH, Vasků A, Jurajda M, Vácha J (2002) Polymorphism Ncol in tumor necrosis factor B is associated with fasting glycemia and lipid parameters in healthy non-obese Caucasian subjects. Diabetes Metab 28:231–237
Kin RJ, Becker RC (2003) Association between factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 146:948–957
Leigh SE, Foster AH, Whittall RA, Hubbart CS, Humphries SE (2008) Update and analysis of the University College London low-density lipoprotein receptor familial hypercholesterolemia database. Ann Hum Genet 72:485–498
Li XX, Liu JP, Cheng JQ et al (2009) Intercellular adhesion molecule-1 gene K469E polymorphism and ischemic stroke: a case–control study in a Chinese population. Mol Biol Rep 36:1565–1571
Licata G, Tuttolomondo A, Di Raimondo D, Corrao S, Sciacca D, Pinto A (2009) Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischemic stroke. Trombos Haemost 101:929–937
Liu T, Clark RK, McDonnell PC et al (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25:1481–1488
Maeda Y, Matsumoto M, Hori O et al (1994) Hypoxia/reoxygenation-mediated induction of astrocyte IL 6: a paracrine mechanism potentially enhancing neuron survival. J Exp Med 180:2297–2308
Malard L, Kakinami L, O’Loughlin J et al (2013) The association between the Angiotensin-Converting Enzyme-2 gene and blood pressure in a cohort study of adolescents. BMC Med Genet 14:117
Manso H, Krug T, Sobral J et al (2010) Variants of the matrix metalloproteinase-2 but not the matrix metalloproteinase-9 genes significantly influence functional outcome after stroke. BMC Med Genet 11:40–49
Manso H, Krug T, Sobral J et al (2011) Variants in the inflammatory IL6 and MPO genes modulate stroke susceptibility through main effects and gene-gene interactions. J Cereb Blood Flow Metab 31:1751–1759
Markus HS (2011) Stroke genetics. Hum Mol Genet 20:R124–R131
Messer G, Spengler U, Jung MC et al (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 173:209–219
Murakami Y, Saito K, Hara A et al (2005) Increases in tumor necrosis factor-alpha following transient global cerebral ischemia do not contribute to neuron death in mouse hippocampus. J Neurochem 93:1616–1622
Oliveira-Filho J, Martins SC, Pontes-Neto OM et al (2012) Guidelines for acute ischemic stroke treatment: part I. Arq Neuropsiquiatr 70:621–629
Ozaki K, Ohnishi Y, Iida A et al (2002) Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 32:650–654
Pena SD, Di Pietro G, Fuchshuber-Moraes M et al (2011) The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS One 6:e17063
Pickering TG, Hall JE, Appel LJ et al (2005) Recommendation for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the american heart association council on high blood pressure research. Hypertension 45:142–161
Pola R, Flex A, Gaetani E, Flore R, Serricchio M, Pola P (2003) Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 34:881–885
Robertson J, Beaulieu JM, Doroudchi MM, Durham HD, Julien JP, Mushynski WE (2001) Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor alpha. J Cell Biol 155:217–226
Rohr J, Kittner S, Feeser B et al (1996) Traditional risk factors and ischemic stroke in young adults. The Baltimore-Washington cooperative young stroke study. Arch Neurol 53:603–607
Romano M, Sironi M, Toniatti C et al (1997) Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6:315–325
Rosenberg GA, Estrada EY, Dencoff JE (1998) Matrix metalloproteinases and TIMPs are associated with blood–brain barrier opening after reperfusion in rat brain. Stroke 29:2189–2195
Rost NS, Wolf PA, Kase CS et al (2001) Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32:2575–2579
Sacco RI, Ellenberg JH, Mohr JP et al (1989) Infarcts of undetermined cause: the NINCDS stroke data bank. Ann Neurol 25:382–390
Smith CJ, Emsley HC, Gavin CM et al (2004) Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 4:2
Soare AM, Popa C (2010) Deficiencies of proteins C, S and antithrombin and factor V Leiden and the risk of ischemic strokes. J Med Life 3:235–238
Szolnoki Z, Havasi V, Talián G et al (2005) Lymphotoxin-alpha gene 252G allelic variant is a risk factor for large-vessel-associated ischemic stroke. J Mol Neurosci 27:205–211
Traylor M, Farrall M, Holliday EG et al (2012) Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol 11:951–962
Tsytsykova AV, Rajsbaum R, Falvo JV, Ligeiro F, Neely SR, Goldfeld AE (2007) Activation-dependent intrachromosomal interactions formed by the TNF gene promoter and two distal enhancers. PNAS 104:16850–16855
Tuttolomondo A, Di Sciacca R, Di Raimondo D et al (2009) Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J Neuroimmunol 215:84–89
Tuttolomondo A, Di Raimondo D, Forte GI et al (2012) Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine 58:398–405
Um JY, An NH, Kim HM (2003) TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction. J Mol Neurosci 21:167–171
Wang Q, Tang XN, Yenari MA (2007) The inflammatory response in stroke. J Neuroimmunol 184:53–68
Wang Q, Ding H, Tang J-R et al (2009a) C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the chinese Han population. Acta Pharmacol Sin 30:291–298
Wang X, Cheng S, Brophy VH et al (2009b) A meta-analysis of candidate gene polymorphisms and ischemic stroke in six study populations: association of lymphotoxin-alpha in non-hypertensive patients. Stroke 40:683–695
Welsh P, Lowe GD, Chalmers J et al (2008) Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke 39:2226–2230
Whiteley W, Wardlaw J, Dennis M et al (2012) The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke 43:86–91
Yamada Y, Metoki N, Yoshida H et al (2006) Genetic risk for ischemic and hemorrhagic stroke. Arterioscler Thromb Vasc Biol 26:1920–1925
Acknowledgments
The study was supported by Institutional Program for Scientific Initiation Scholarship (PIBIC) of the National Council for Scientific and Technological Development (CNPq), State University of Londrina (PROPPG), and Bayer HealthCare. We thank the staff of University Hospital of State University of Londrina and HUTec Foundation for technical and administrative supports.
Conflict of interest statement
All the authors declare that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Sousa Parreira, J., Kallaur, A.P., Lehmann, M.F. et al. Tumor necrosis factor beta NcoI polymorphism (rs909253) is associated with inflammatory and metabolic markers in acute ischemic stroke. Metab Brain Dis 30, 159–167 (2015). https://doi.org/10.1007/s11011-014-9584-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-014-9584-6